Vaniqa - topical cream to slow the growth of unwanted facial hair in women

UNIQUE

VANIQA® is the only topical prescription treatment that slows the growth of facial hair in women.

Mechanism of Action

Topical eflornithine has an innovative mechanism of action which irreversibly inhibits the effect of ornithine decarboxylase. This enzyme is integral in hair shaft production by the follicle.

In pre-clinical and clinical studies, eflornithine was shown to reduce the rate of hair growth.

 

 

EFFECTIVE

VANIQA® has shown marked improvement in results as already as 4-8 weeks. Nearly 70% of patients treated with VANIQA® showed at least improved status after 24 weeks of treatment.

 

 

EXCELLENT SAFETY PROFILE

ADR similar to placebo (Some patients (14.2%) experienced burning, stinging, tingling compared to placebo (5.0%))